Chanté Muller holds a doctoral degree in medicinal biochemistry from the University of North Carolina Greensboro, USA. During her studies, she earned an NIH National Research Service Award fellowship awarded for her project focused on the interactions between cannabinoid ligands and the ionotropic cannabinoid receptor TRPV1. Her PhD studies resulted in five first author publications, one of which has been cited over 300 times.
Chanté is currently studying novel oxyendocannabinoidome (oxy-eCBome) metabolites and their cellular targets and physiological effects - the goal of which being to investigate some hypothesized relationships of the oxy-eCBome with the gut microbiome/eCBome axis and its role in systemic inflammation.